Similar articles for PMID: 29065786

Year	Number of Results
2002	2
2003	3
2004	2
2005	3
2006	4
2007	5
2008	3
2009	10
2010	6
2011	4
2012	2
2013	9
2014	6
2015	1
2016	5
2017	6
2018	9
2019	6
2020	7
2021	5
2022	8
2023	6
2024	2

1

Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline.

Osorio S, Escudero-Vilaplana V, Reguilón-Gallego L, Gómez-Centurión I, Díez JL, Ferrer-Marín F. Osorio S, et al. J Oncol Pharm Pract. 2017 Jan 1:1078155217735689. doi: 10.1177/1078155217735689. Online ahead of print. J Oncol Pharm Pract. 2017. PMID: 29065786

2

Novel Score-based Decision Approach in Chronic Myeloid Leukemia Patients After Acute Toxic Imatinib-induced Liver Injury.

Lopina N, Dmytrenko I, Hamov D, Lopin D, Dyagil I. Lopina N, et al. Cureus. 2019 Apr 9;11(4):e4411. doi: 10.7759/cureus.4411. Cureus. 2019. PMID: 31245199 Free PMC article. Review.

3

Acute pancreatitis in a patient treated with imatinib and gefitinib.

Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Álvarez R, Herranz A, Sanjurjo M. Escudero-Vilaplana V, et al. J Oncol Pharm Pract. 2021 Jun;27(4):980-983. doi: 10.1177/1078155220949639. Epub 2020 Aug 16. J Oncol Pharm Pract. 2021. PMID: 32799779

4

Imatinib and Panax ginseng: a potential interaction resulting in liver toxicity.

Bilgi N, Bell K, Ananthakrishnan AN, Atallah E. Bilgi N, et al. Ann Pharmacother. 2010 May;44(5):926-8. doi: 10.1345/aph.1M715. Epub 2010 Mar 23. Ann Pharmacother. 2010. PMID: 20332334

5

Imatinib-induced fatal acute liver failure.

Ridruejo E, Cacchione R, Villamil AG, Marciano S, Gadano AC, Mandó OG. Ridruejo E, et al. World J Gastroenterol. 2007 Dec 28;13(48):6608-111. doi: 10.3748/wjg.v13.i48.6608. World J Gastroenterol. 2007. PMID: 18161937 Free PMC article.

6

Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors.

Tonyali O, Coskun U, Yildiz R, Karakan T, Demirci U, Akyurek N, Benekli M, Buyukberber S. Tonyali O, et al. Med Oncol. 2010 Sep;27(3):768-73. doi: 10.1007/s12032-009-9284-y. Epub 2009 Aug 7. Med Oncol. 2010. PMID: 19662540

7

Imatinib mesylate-induced acute hepatotoxicity.

Frikha I, Fakhfakh Y, Sahnoun R, Chtourou L, Medhaffar M, Elloumi M. Frikha I, et al. J Oncol Pharm Pract. 2023 Dec;29(8):2027-2030. doi: 10.1177/10781552231188307. Epub 2023 Jul 18. J Oncol Pharm Pract. 2023. PMID: 37464887

8

Introduction of imatinib as first-line therapy for chronic myeloid leukemia in Cuba.

Morán VP, Baute RG, Facundo JC, Ramírez PH, Núñez AA, Martínez EE, Cabrera OM, Padrón CH, Otero AG, Uría JC, Estrada EE, Díaz RM, Virgil AM, Sánchez KL, Cabeza AH. Morán VP, et al. MEDICC Rev. 2011 Jan;13(1):35-40. doi: 10.37757/MR2011V13.N1.9. MEDICC Rev. 2011. PMID: 21273957 Free article. Clinical Trial.

9

Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity.

Harbaum L, Marx A, Goekkurt E, Schafhausen P, Atanackovic D. Harbaum L, et al. Int J Hematol. 2014 Jan;99(1):91-4. doi: 10.1007/s12185-013-1474-x. Epub 2013 Nov 22. Int J Hematol. 2014. PMID: 24264834

10

Evaluation of the safety of imatinib mesylate in 200 iraqi patients with chronic myeloid leukemia in the chronic phase: single-center study.

Matti BF, Alwan AF, Alwan AF. Matti BF, et al. Turk J Haematol. 2013 Dec;30(4):387-93. doi: 10.4274/Tjh.2012.0135. Epub 2013 Dec 5. Turk J Haematol. 2013. PMID: 24385829 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year